Flexion Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Flexion Therapeutics, Inc. reported Increase (Decrease) in Deferred Revenue of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2021-11-12
- Flexion Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Flexion Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2020-12-31 was $0.00.
- Flexion Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2020-09-30 was $5.00M.
- Flexion Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2020 was $10.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $5.00M derived: sum of 2 quarters · filed 2021-11-12 | $10.00M 10-K · filed 2021-03-10 | |
| 2020-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $10.00M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $5.00M 10-Q · filed 2021-08-04 |